Medtronic plc logo
Medtronic plc (MDT)
Compare

Medtronic plc (MDT) Free Cash Flow Yield: 5.14%

Is Medtronic plc’s free cash flow yield high or low?

Medtronic plc's free cash flow yield of 5.14% is 19% above its 5-year average of 4.31%, near the high end of its 5-year range (2.67%–5.69%).

The free cash flow yield for Medtronic plc (MDT) is 5.14% as of Tuesday, June 9, 2026. It is above its 12-month average by 13.86% (4.51%).

MDT Free Cash Flow Yield Chart

MDT Free Cash Flow Yield
5.14%+5.76% 1Y
Zoom

MDT Average Free Cash Flow Yield Chart

MDT Current vs Average Free Cash Flow Yield Chart

MDT Free Cash Flow Yield Metrics

FREE CASH FLOW YIELD

5.14%

FREE CASH FLOW YIELD AVG TTM

4.51%

FREE CASH FLOW YIELD AVG 3Y

4.48%

FREE CASH FLOW YIELD AVG 5Y

4.31%

FREE CASH FLOW YIELD AVG 10Y

4.14%

FREE CASH FLOW YIELD AVG 15Y

5.17%

FREE CASH FLOW YIELD AVG 20Y

5.39%

CURRENT VS TTM AVG

+13.86%

CURRENT VS 3Y AVG

+14.76%

CURRENT VS 5Y AVG

+19.28%

CURRENT VS 10Y AVG

+24.05%

CURRENT VS 15Y AVG

-0.64%

CURRENT VS 20Y AVG

-4.63%

MDT Competitors' Free Cash Flow Yield

NAMEMARKET CAPFREE CASH FLOW YIELDTTM3Y5Y
Medtronic plc (MDT)5.14%4.51%4.48%4.31%
Vertex Pharmaceuticals Incorporated (VRTX)$110.77B3.31%3.05%3.42%3.85%
Bristol-Myers Squibb Company (BMY)$115.34B10.32%13.32%12.26%10.96%
Elevance Health Inc. (ELV)$92.17B6.90%5.88%5.05%6.07%
CVS Health Corporation (CVS)$123.84B5.96%6.53%9.26%10.66%
Cigna Corporation (CI)$78.04B9.82%8.60%9.51%9.22%
Danaher Corporation (DHR)$133.37B3.95%3.48%3.47%3.67%
Pfizer Inc. (PFE)$146.48B6.44%7.36%5.93%7.34%
Regeneron Pharmaceuticals, Inc. (REGN)$62.59B6.35%5.46%4.50%5.45%
Intuitive Surgical, Inc. (ISRG)$151.09B1.85%1.28%0.87%1.09%

Yield Comparison

FCF Yield

5.14%

Earnings Yield

4.55%

Dividend Yield

3.46%

Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100

How FCF Yield is used:

  • Shows free cash flow after capital expenditures relative to market cap
  • Can be compared with earnings yield and dividend yield
  • Can be compared with the company's historical range
  • Can be compared with peers that report positive free cash flow

FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.

Medtronic plc Free Cash Flow Yield Formula & Definition

FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Medtronic plc Free Cash Flow Yield FAQ

What is the free cash flow yield for Medtronic plc (MDT)?
The free cash flow yield for MDT stock is 5.14%.
Is Medtronic plc's free cash flow yield high or low?
Medtronic plc's free cash flow yield of 5.14% is 19% above its 5-year average of 4.31%, near the high end of its 5-year range (2.67%–5.69%).
What is the TTM average free cash flow yield for Medtronic plc (MDT)?
The TTM average free cash flow yield for MDT stock is 4.51%.
What is the 3Y average free cash flow yield for Medtronic plc (MDT)?
The 3Y average free cash flow yield for MDT stock is 4.48%.
What is the 5Y average free cash flow yield for Medtronic plc (MDT)?
The 5Y average free cash flow yield for MDT stock is 4.31%.
What is the 10Y average free cash flow yield for Medtronic plc (MDT)?
The 10Y average free cash flow yield for MDT stock is 4.14%.
What is the 15Y average free cash flow yield for Medtronic plc (MDT)?
The 15Y average free cash flow yield for MDT stock is 5.17%.
What is the 20Y average free cash flow yield for Medtronic plc (MDT)?
The 20Y average free cash flow yield for MDT stock is 5.39%.

Medtronic plc Free Cash Flow Yield History

DATEFREE CASH FLOW YIELD
2026-06-095.14%
2026-06-085.22%
2026-06-055.16%
2026-06-045.14%
2026-06-035.41%
2026-06-025.69%
2026-06-015.68%
2026-05-295.69%
2026-05-285.56%
2026-05-275.53%
2026-05-265.41%
2026-05-225.34%
2026-05-215.37%
2026-05-205.37%
2026-05-195.34%
2026-05-185.43%
2026-05-155.52%
2026-05-145.46%
2026-05-135.51%
2026-05-125.47%
2026-05-115.63%
2026-05-085.52%
2026-05-075.39%
2026-05-065.41%
2026-05-055.40%
2026-05-045.36%
2026-05-015.25%
2026-04-305.19%
2026-04-295.29%
2026-04-285.13%
2026-04-275.07%
2026-04-245.04%
2026-04-235.01%
2026-04-225.05%
2026-04-215.12%
2026-04-204.94%
2026-04-174.87%
2026-04-164.90%
2026-04-154.82%
2026-04-144.77%
2026-04-134.77%
2026-04-104.81%
2026-04-094.78%
2026-04-084.74%
2026-04-074.86%
2026-04-064.87%
2026-04-024.85%
2026-04-014.88%
2026-03-314.85%
2026-03-304.90%
2026-03-274.82%
2026-03-264.79%
2026-03-254.78%
2026-03-244.85%
2026-03-234.82%
2026-03-204.87%
2026-03-194.83%
2026-03-184.81%
2026-03-174.75%
2026-03-164.76%
2026-03-134.82%
2026-03-124.81%
2026-03-114.72%
2026-03-104.67%
2026-03-094.60%
2026-03-064.62%
2026-03-054.51%
2026-03-044.39%
2026-03-034.34%
2026-03-024.28%
2026-02-274.30%
2026-02-264.33%
2026-02-254.35%
2026-02-244.34%
2026-02-234.10%
2026-02-204.18%
2026-02-194.14%
2026-02-184.11%
2026-02-174.19%
2026-02-134.07%
2026-02-124.01%
2026-02-114.00%
2026-02-103.99%
2026-02-093.98%
2026-02-063.93%
2026-02-053.93%
2026-02-043.97%
2026-02-033.92%
2026-02-023.94%
2026-01-303.93%
2026-01-294.00%
2026-01-284.01%
2026-01-274.02%
2026-01-264.02%
2026-01-234.01%
2026-01-223.99%
2026-01-214.03%
2026-01-204.10%
2026-01-164.18%
2026-01-154.08%
2026-01-144.10%
2026-01-134.19%
2026-01-124.17%
2026-01-094.15%
2026-01-084.10%
2026-01-074.05%
2026-01-064.03%
2026-01-054.15%
2026-01-024.21%
2025-12-314.21%
2025-12-304.18%
2025-12-294.21%
2025-12-264.19%
2025-12-244.16%
2025-12-234.15%
2025-12-224.14%
2025-12-194.10%
2025-12-184.11%
2025-12-174.11%
2025-12-164.14%
2025-12-154.10%
2025-12-124.05%
2025-12-114.05%
2025-12-104.01%
2025-12-094.06%
2025-12-083.99%
2025-12-053.99%
2025-12-043.97%
2025-12-033.97%
2025-12-023.96%
2025-12-013.91%
2025-11-283.84%
2025-11-263.85%
2025-11-253.84%
2025-11-243.99%
2025-11-214.07%
2025-11-204.15%
2025-11-194.11%
2025-11-184.09%
2025-11-174.28%
2025-11-144.30%
2025-11-134.29%
2025-11-124.30%
2025-11-114.32%
2025-11-104.45%
2025-11-074.47%
2025-11-064.57%
2025-11-054.56%
2025-11-044.56%
2025-11-034.57%
2025-10-314.54%
2025-10-304.53%
2025-10-294.49%
2025-10-284.42%
2025-10-274.38%
2025-10-244.40%
2025-10-234.37%
2025-10-224.30%
2025-10-214.30%
2025-10-204.30%
2025-10-174.30%
2025-10-164.33%
2025-10-154.32%
2025-10-144.27%
2025-10-134.31%
2025-10-104.32%
2025-10-094.27%
2025-10-084.21%
2025-10-074.19%
2025-10-064.19%
2025-10-034.22%
2025-10-024.32%
2025-10-014.35%
2025-09-304.33%
2025-09-294.38%
2025-09-264.37%
2025-09-254.37%
2025-09-244.30%
2025-09-234.34%
2025-09-224.35%
2025-09-194.33%
2025-09-184.31%
2025-09-174.36%
2025-09-164.37%
2025-09-154.41%
2025-09-124.38%
2025-09-114.37%
2025-09-104.46%
2025-09-094.38%
2025-09-084.43%
2025-09-054.43%
2025-09-044.44%
2025-09-034.47%
2025-09-024.42%
2025-08-294.44%
2025-08-284.48%
2025-08-274.48%
2025-08-264.47%
2025-08-254.37%
2025-08-224.34%
2025-08-214.42%
2025-08-204.32%
2025-08-194.48%
2025-08-184.34%
2025-08-154.33%
2025-08-144.38%
2025-08-134.33%
2025-08-124.37%
2025-08-114.34%
2025-08-084.33%
2025-08-074.41%
2025-08-064.51%
2025-08-054.49%
2025-08-044.49%
2025-08-014.51%
2025-07-314.46%
2025-07-304.39%
2025-07-294.36%
2025-07-284.38%
2025-07-254.33%
2025-07-244.36%
2025-07-234.38%
2025-07-224.39%
2025-07-214.49%
2025-07-184.49%
2025-07-174.50%
2025-07-164.48%
2025-07-154.51%
2025-07-144.49%
2025-07-114.48%
2025-07-104.50%
2025-07-094.52%
2025-07-084.55%
2025-07-074.59%
2025-07-034.56%
2025-07-024.56%
2025-07-014.54%
2025-06-304.62%
2025-06-274.68%
2025-06-264.67%
2025-06-254.68%
2025-06-244.68%
2025-06-234.68%
2025-06-204.66%
2025-06-184.96%
2025-06-174.93%
2025-06-164.84%
2025-06-134.87%
2025-06-124.80%
2025-06-114.83%
2025-06-104.83%
2025-06-094.86%
2025-06-064.86%
2025-06-054.89%
2025-06-044.97%
2025-06-034.97%
2025-06-025.08%
2025-05-305.12%
2025-05-295.16%
2025-05-285.23%

Showing the most recent 260 of 5,031 data points. The chart above shows the full history.

About Medtronic plc

Medtronic plc is a leading global medical technology enterprise that invents, develops, manufactures, and distributes an extensive range of device-based medical therapies. These solutions serve healthcare systems, clinicians, physicians, and patients across the world. The company's operations are categorized into several key portfolios: Cardiovascular Portfolio: This segment focuses on cardiac health, providing technologies for heart rhythm management, including implantable pacemakers, defibrillators, and monitoring systems, alongside cardiac ablation tools and remote patient software. It also addresses structural heart issues with products like aortic and pulmonary valves, surgical repair devices, and endovascular stent grafts, in addition to offerings for percutaneous coronary interventions (e.g., angioplasty balloons). Medical Surgical Portfolio: Offering a broad spectrum of surgical instruments and therapies, this division includes staples, vessel sealing devices, wound closure products, and electrosurgical equipment. It also pioneers surgical artificial intelligence and robotic-assisted platforms, alongside solutions for hernia repair, gynecology, lung conditions, minimally invasive gastrointestinal and hepatologic diagnostics, patient monitoring, airway management, ventilation therapies, and renal disease. Neuroscience Portfolio: This division delivers specialized products for a diverse group of medical professionals, such as spinal surgeons, neurosurgeons, neurologists, pain management specialists, and ENT experts. Its offerings span energy surgical instruments, advanced image-guided and intra-operative imaging systems, robotic guidance for spine procedures, and therapies targeting the brain's vasculature. Diabetes Operating Unit: Dedicated to diabetes management, this unit provides innovative solutions like insulin pumps and their associated consumables, continuous glucose monitoring (CGM) systems, and smart insulin pen technologies. Established in 1949, Medtronic plc maintains its corporate headquarters in Dublin, Ireland.

Galway
95,000 employees
Healthcare / Medical - Devices
Sector
Healthcare
Industry
Medical - Devices
CEO
Geoffrey Straub Martha